Free Trial

Heart Test Laboratories Q3 2024 Earnings Report

Heart Test Laboratories logo
$3.83 +0.41 (+11.99%)
(As of 12/20/2024 05:31 PM ET)

Heart Test Laboratories EPS Results

Actual EPS
-$3.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Heart Test Laboratories Revenue Results

Actual Revenue
$0.02 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Heart Test Laboratories Announcement Details

Quarter
Q3 2024
Time
N/A

Conference Call Resources

⭕ [URGENT] Buy Alert just triggered (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

Heart Test Laboratories Earnings Headlines

HeartSciences Withdraws Public Offering, Citing Flexible Financing Strategy
⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
HeartSciences Inc. HSCS (U.S.: Nasdaq)
Heart Test announces CMS included AI-ECG tech in 2025 OPPS final rule
See More Heart Test Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Heart Test Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heart Test Laboratories and other key companies, straight to your email.

About Heart Test Laboratories

Heart Test Laboratories (NASDAQ:HSCS), a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

View Heart Test Laboratories Profile

More Earnings Resources from MarketBeat

Upcoming Earnings